Dr. Alexander Lyon presented “Prevalence of CVD and Assessment of CV Risk in Patients with Prostate Cancer” at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between October 14th and 16th 2016.
STOP-6 was accredited for CME by the European Accreditation Council for CME (UEMS-EACCME).
The meeting was organized by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal.
Funding to support this educational activity was provided by FERRING Pharmaceuticals. FERRING did not influence meeting content and the views expressed during the meeting represent only those of the faculty.
Keywords: prostate cancer, cardiovascular disease
How to cite: Lyon, Alexander. “Prevalence of CVD and Assessment of CV Risk in Patients with Prostate Cancer” Grand Rounds in Urology. October 14-16, 2016. Accessed Dec 2024. https://dev.grandroundsinurology.com/prevalence-cvd-assessment-cv-risk-patients-prostate-cancer.
This presentation was made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between the 14th and 16th October.
STOP-6 was accredited for CME by the European Accreditation Council for CME (UEMS-EACCME).
The meeting was organised by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal.
Funding to support this educational activity was provided by FERRING Pharmaceuticals. FERRING did not influence meeting content and the views expressed during the meeting represent only those of the faculty.
ABOUT THE AUTHOR
Alexander Lyon is a Clinical Senior Lecturer in Cardiology at Imperial College London and a Consultant Cardiologist at the Royal Brompton Hospital. Dr. Lyon studied Medicine at Oxford University, where he took a 1st Class degree in Physiological Sciences in 1995, achieving second place in the final honors school.
After qualifying from the John Radcliffe Medical School in 1998, he trained as a junior doctor in Cardiology in Oxford, at the Royal Brompton Hospital in London, and in Sydney, Australia. He joined the Cardiac Medicine research group of Professor Sian Harding and Professor Philip Poole-Wilson, where he studied the influence of cardiac gene therapy upon ventricular arrhythmia generation. He was awarded an MRC Clinical Research Training Fellowship in 2005. He completed his Ph.D. in 2008 and spent his first postdoctoral year studying the spatiotemporal patterns of mitochondrial function in the lab of Fadi Akar and Roger Hajjar at Mount Sinai School of Medicine in New York City. He was appointed Walport Clinical Lecturer in Cardiology at Imperial College in 2008 and completed his specialty training at St. Mary’s Hospital and the Royal Brompton Hospital.
Dr. Lyon was appointed a Senior Lecturer and Consultant Cardiologist in January 2012.
